Summary
This comprehensive narrative review, published in the Journal of Nanobiotechnology (2025), synthesises current knowledge on the structure of lignin — a major plant cell wall polymer — and its translation into biomedical biomaterials. It likely covers extraction and modification strategies that yield nanoparticles, hydrogels, and composite scaffolds with properties suitable for drug delivery, antimicrobial applications, and tissue repair. The review is positioned at the intersection of green chemistry and nanomedicine, highlighting lignin's abundance as an agricultural and forestry by-product as a driver for its biomedical valorisation.
UK applicability
The findings are not directly applicable to UK farming or food systems practice, but may be of indirect relevance to UK bioeconomy and agri-industrial policy, given that lignin is a major by-product of UK forestry and lignocellulosic biomass processing. Researchers and industries involved in valorising agricultural residues may find the biomedical applications outlined here relevant to circular economy strategies.
Key measures
Lignin structural features (e.g. monolignol composition, molecular weight); biomaterial properties (e.g. antioxidant activity, biocompatibility, drug loading capacity); biomedical application outcomes (e.g. antimicrobial efficacy, cytotoxicity, in vivo performance)
Outcomes reported
The review likely examines the structural diversity of lignin and how it can be processed or functionalised into biomaterials suitable for biomedical applications, including drug delivery, wound healing, and tissue engineering. It probably assesses the physicochemical properties of lignin nanoparticles and other lignin-based constructs relevant to therapeutic performance.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.